Literature DB >> 26589375

Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.

Eleftheria Barlaka1, Eleftheria Galatou1, Kyriakos Mellidis1, Tanya Ravingerova2, Antigone Lazou1.   

Abstract

Peroxisome proliferator-activated receptors, PPARα, PPARβ/δ, and PPARγ, are a group of nuclear receptors that function as transcriptional regulators of lipid metabolism, energy homeostasis, and inflammation. Given the role of metabolism imbalance under pathological states of the heart, PPARs have emerged as important therapeutic targets, and accumulating evidence highlights their protective role in the improvement of cardiac function under diverse pathological settings. Although the role of PPARs in the regulation of cardiac substrate utilization preference and energy homeostasis is well documented, their effects related to the regulation of cellular inflammatory and redox responses in the heart are less studied. In this review, we provide an overview on recent progress with respect to understanding the role of the nonmetabolic effects of PPARs in cardiac dysfunction, namely during ischemia/reperfusion injury, hypertrophy, and cardiac failure, and highlight the mechanisms underlying the protective effects against inflammation, oxidative stress, and cell death. The role of receptor-independent, nongenomic effects of PPAR agonists is also discussed.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Cardiac disorders; Inflammation; Nonmetabolic; Nuclear receptors; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 26589375     DOI: 10.1111/1755-5922.12166

Source DB:  PubMed          Journal:  Cardiovasc Ther        ISSN: 1755-5914            Impact factor:   3.023


  11 in total

1.  Qiliqiangxin attenuates isoproterenol-induced cardiac remodeling in mice.

Authors:  Jialiang Zhang; Mengyuan Huang; Shutong Shen; Xiaoting Wu; Xiaodong Wu; Ping Lv; Haifeng Zhang; Hui Wang; Xinli Li
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 2.  Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Authors:  Ioanna Andreadou; Efstathios K Iliodromitis; Antigone Lazou; Anikó Görbe; Zoltán Giricz; Rainer Schulz; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2017-02-08       Impact factor: 8.739

3.  Cardiomyocyte peroxisome proliferator-activated receptor α is essential for energy metabolism and extracellular matrix homeostasis during pressure overload-induced cardiac remodeling.

Authors:  Xia Wang; Xin-Xin Zhu; Shi-Yu Jiao; Dan Qi; Bao-Qi Yu; Guo-Min Xie; Ye Liu; Yan-Ting Song; Qing Xu; Qing-Bo Xu; Frank J Gonzalez; Jie Du; Xiao-Min Wang; Ai-Juan Qu
Journal:  Acta Pharmacol Sin       Date:  2021-08-10       Impact factor: 7.169

Review 4.  European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).

Authors:  Javier Egea; Isabel Fabregat; Yves M Frapart; Pietro Ghezzi; Agnes Görlach; Thomas Kietzmann; Kateryna Kubaichuk; Ulla G Knaus; Manuela G Lopez; Gloria Olaso-Gonzalez; Andreas Petry; Rainer Schulz; Jose Vina; Paul Winyard; Kahina Abbas; Opeyemi S Ademowo; Catarina B Afonso; Ioanna Andreadou; Haike Antelmann; Fernando Antunes; Mutay Aslan; Markus M Bachschmid; Rui M Barbosa; Vsevolod Belousov; Carsten Berndt; David Bernlohr; Esther Bertrán; Alberto Bindoli; Serge P Bottari; Paula M Brito; Guia Carrara; Ana I Casas; Afroditi Chatzi; Niki Chondrogianni; Marcus Conrad; Marcus S Cooke; João G Costa; Antonio Cuadrado; Pham My-Chan Dang; Barbara De Smet; Bilge Debelec-Butuner; Irundika H K Dias; Joe Dan Dunn; Amanda J Edson; Mariam El Assar; Jamel El-Benna; Péter Ferdinandy; Ana S Fernandes; Kari E Fladmark; Ulrich Förstermann; Rashid Giniatullin; Zoltán Giricz; Anikó Görbe; Helen Griffiths; Vaclav Hampl; Alina Hanf; Jan Herget; Pablo Hernansanz-Agustín; Melanie Hillion; Jingjing Huang; Serap Ilikay; Pidder Jansen-Dürr; Vincent Jaquet; Jaap A Joles; Balaraman Kalyanaraman; Danylo Kaminskyy; Mahsa Karbaschi; Marina Kleanthous; Lars-Oliver Klotz; Bato Korac; Kemal Sami Korkmaz; Rafal Koziel; Damir Kračun; Karl-Heinz Krause; Vladimír Křen; Thomas Krieg; João Laranjinha; Antigone Lazou; Huige Li; Antonio Martínez-Ruiz; Reiko Matsui; Gethin J McBean; Stuart P Meredith; Joris Messens; Verónica Miguel; Yuliya Mikhed; Irina Milisav; Lidija Milković; Antonio Miranda-Vizuete; Miloš Mojović; María Monsalve; Pierre-Alexis Mouthuy; John Mulvey; Thomas Münzel; Vladimir Muzykantov; Isabel T N Nguyen; Matthias Oelze; Nuno G Oliveira; Carlos M Palmeira; Nikoletta Papaevgeniou; Aleksandra Pavićević; Brandán Pedre; Fabienne Peyrot; Marios Phylactides; Gratiela G Pircalabioru; Andrew R Pitt; Henrik E Poulsen; Ignacio Prieto; Maria Pia Rigobello; Natalia Robledinos-Antón; Leocadio Rodríguez-Mañas; Anabela P Rolo; Francis Rousset; Tatjana Ruskovska; Nuno Saraiva; Shlomo Sasson; Katrin Schröder; Khrystyna Semen; Tamara Seredenina; Anastasia Shakirzyanova; Geoffrey L Smith; Thierry Soldati; Bebiana C Sousa; Corinne M Spickett; Ana Stancic; Marie José Stasia; Holger Steinbrenner; Višnja Stepanić; Sebastian Steven; Kostas Tokatlidis; Erkan Tuncay; Belma Turan; Fulvio Ursini; Jan Vacek; Olga Vajnerova; Kateřina Valentová; Frank Van Breusegem; Lokman Varisli; Elizabeth A Veal; A Suha Yalçın; Olha Yelisyeyeva; Neven Žarković; Martina Zatloukalová; Jacek Zielonka; Rhian M Touyz; Andreas Papapetropoulos; Tilman Grune; Santiago Lamas; Harald H H W Schmidt; Fabio Di Lisa; Andreas Daiber
Journal:  Redox Biol       Date:  2017-05-18       Impact factor: 11.799

5.  Peroxisome Proliferator-Activated Receptor α Reduces Endothelin-1-Caused Cardiomyocyte Hypertrophy by Inhibiting Nuclear Factor-κB and Adiponectin.

Authors:  Hsu-Lung Jen; Po-Len Liu; Yung-Hsiang Chen; Wei-Hsian Yin; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Mediators Inflamm       Date:  2016-10-11       Impact factor: 4.711

6.  Effect of Pioglitazone in Preventing In-Stent Restenosis after Percutaneous Coronary Intervention in Patients with Type 2 Diabetes: A Meta-Analysis.

Authors:  Shi-Jie Zhao; Zhao-Shuang Zhong; Guo-Xian Qi; Li-Ye Shi; Ling Chen; Wen Tian
Journal:  PLoS One       Date:  2016-05-10       Impact factor: 3.240

7.  Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repair.

Authors:  Ajit Magadum; Yishu Ding; Lan He; Teayoun Kim; Mohankrishna Dalvoy Vasudevarao; Qinqiang Long; Kevin Yang; Nadeera Wickramasinghe; Harsha V Renikunta; Nicole Dubois; Gilbert Weidinger; Qinglin Yang; Felix B Engel
Journal:  Cell Res       Date:  2017-06-16       Impact factor: 25.617

Review 8.  The Peroxisome-Mitochondria Connection: How and Why?

Authors:  Marc Fransen; Celien Lismont; Paul Walton
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

9.  Protecting the Mitochondria in Cardiac Disease.

Authors:  Antigone Lazou; Chrishan J Ramachandra
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

10.  Cardioprotective Effects of PPARβ/δ Activation against Ischemia/Reperfusion Injury in Rat Heart Are Associated with ALDH2 Upregulation, Amelioration of Oxidative Stress and Preservation of Mitochondrial Energy Production.

Authors:  Ioanna Papatheodorou; Eleftheria Galatou; Georgios-Dimitrios Panagiotidis; Táňa Ravingerová; Antigone Lazou
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.